John Leamon is IsoPlexis’ SVP of Research and Development Integration. John is responsible for integrating and optimizing research, development, and production teams to meet the overwhelming customer demand for IsoPlexis platforms and assays. John’s 21 years of biotechnology experience span a range of companies, including start-ups (454 Life Sciences, RainDance technologies, Ion Torrent, CyVek, Quantum-Si, and Detect,) and established global companies (Qiagen, Life Technology). John was a key inventor of the system. He is an author on 24 peer-reviewed publications and an inventor on over 40 patents and applications. John obtained his Ph.D. in Physiology and Neurobiology from the University of Connecticut, with post-doctoral work at Yale Medical School.
Current role